http://healthyamericans.org/reports/h1n1/TFAH2009challengesahead.pdf
CDC's Strategic National Stockpile (SNS) contains approximately: 39.7 million regimens of oseltamivir capsules (Tamiflu), 9,279 regimens of oral suspension oseltamivir, and 10.3 million regimens of zanamivir (Relenza).
In addition to the antivirals received from the federal portion of the stockpile, according to HHS, as of September 10, 2009, state and local jurisdictions have stockpiled over 25 million treatment courses of antivirals, which is about five million short of the national goal.
Combining the federal allocations received by states with states' purchases, 13 states do not currently have enough antivirals to cover 20 percent of their population And another 11 states have only enough antivirals to cover between 20 and 25 percent of their population (combining their federal allocation and state purchases)
As of November 2008, there were just over 3.8 million regimens of pediatric antiviral formulations in the federal stockpile to treat a potentialpandemic flu for the nation's 73.6 million children. The government has not set any target for stockpiling pediatric antivirals, even though children and adolescents are known to often be disproportionately affected by contagious respiratory illnesses, and have been especially affected by the current H1N1 outbreak.
The quantity of non-pharmaceutical interventions for pandemic influenza in the SNS, such as N-95 respirator masks and surgical masks, falls far short of what may be needed. As of the spring of 2009, the U.S. stockpile contained 105.8 million N-95 respirators and 51.7 million surgical masks. CDC reports that 25 million N-95 respirator masks were distributed from the SNS during the spring, reducing the nationally-available number of N-95s to 79.7 million. The SNS also contains 37.7 million surgical masks, which are not considered effective protection against H1N1. This is short of the number that many expertsbelieve would be adequate, but no action has been taken to replenish this supply and there are some questions if additional respirator masks are available due to limited availability.
CDC's Strategic National Stockpile (SNS) contains approximately: 39.7 million regimens of oseltamivir capsules (Tamiflu), 9,279 regimens of oral suspension oseltamivir, and 10.3 million regimens of zanamivir (Relenza).
In addition to the antivirals received from the federal portion of the stockpile, according to HHS, as of September 10, 2009, state and local jurisdictions have stockpiled over 25 million treatment courses of antivirals, which is about five million short of the national goal.
Combining the federal allocations received by states with states' purchases, 13 states do not currently have enough antivirals to cover 20 percent of their population And another 11 states have only enough antivirals to cover between 20 and 25 percent of their population (combining their federal allocation and state purchases)
As of November 2008, there were just over 3.8 million regimens of pediatric antiviral formulations in the federal stockpile to treat a potentialpandemic flu for the nation's 73.6 million children. The government has not set any target for stockpiling pediatric antivirals, even though children and adolescents are known to often be disproportionately affected by contagious respiratory illnesses, and have been especially affected by the current H1N1 outbreak.
The quantity of non-pharmaceutical interventions for pandemic influenza in the SNS, such as N-95 respirator masks and surgical masks, falls far short of what may be needed. As of the spring of 2009, the U.S. stockpile contained 105.8 million N-95 respirators and 51.7 million surgical masks. CDC reports that 25 million N-95 respirator masks were distributed from the SNS during the spring, reducing the nationally-available number of N-95s to 79.7 million. The SNS also contains 37.7 million surgical masks, which are not considered effective protection against H1N1. This is short of the number that many expertsbelieve would be adequate, but no action has been taken to replenish this supply and there are some questions if additional respirator masks are available due to limited availability.
